Facebook fracas yields new Merck followers; Watson nabs FDA approval for Yaz copy;

 @FiercePharma: Large-vial woes in Las Vegas: Surgeon sues Allergan over Botox vials that 'encourage reuse,' after Teva/propofol trials. News | Follow @FiercePharma

> Merck & Co. ($MRK) has garnered "hundreds" of new followers, thanks to a public tussle between Merck KGaA and Facebook over the rights to the www.facebook.com/Merck URL. Story

> AstraZeneca ($AZN) and Bristol-Myers Squibb's ($BMY) combination diabetes remedy Komboglyze has won approval from European regulators. News

> Watson Pharmaceuticals ($WPI) won has FDA approval for its version of Bayer's Yaz contraceptive pill, but Bayer is suing Watson for patent infringement. Article

> Indian officials have ordered Sanofi ($SNY) to pay 650 crore rupees, or about $125 million, in capital gains tax related to its buyout of vaccine maker Shantha Biotech. Sanofi, however, maintains it's not liable for the tax. Story

> Perrigo won FDA approval for a generic version of the over-the-counter decongestant Mucinex. Report

> Swiss drugmaker Naari ordered Nebraska officials to return a drug purchased for use in executions, saying it was "wrongfully diverted" to the state by a middleman. News

> Taro Pharmaceutical Industries said board member Ilan Levitech has resigned due to increased time commitments required for the position. More

> Novo Nordisk obtained a €650 million, 5-year revolving credit facility primarily to refinance expiring credit. Report

> Cognizant inked a deal to provide biostatistical and medical reporting services to AstraZeneca ($AZN). Article

Biotech News

 @FierceBiotech: It looks like bone. It feels like bone. For the most part, it acts like bone. And it came off an inkjet printer. Story | Follow @FierceBiotech

 @RyanMFierce: Idera ($IDRA) has rights to one of its TLR drugs, but no pharma partner in German Merck to help fund it. Release | Follow @RyanMFierce

 @MaureenFierce: Swiss pharmaceutical company wants Nebraska to return drug to be used in lethal injection. News | Follow @MaureenFierce

> Pfizer targets miniblockbuster prospects as Lipitor patent expires. Article

> GSK shakes up R&D units during high-profile review. More

Medical Device News

> Boston Sci wins FDA nod for heart failure devices. Item

> QIAGEN to cut up to 10% of workforce. News

> AcuFocus rakes in $65M in funding. Story

Drug Delivery News

> FDA pins approval on new formulation of Ambien. Article

> Royal DSM injects delivery tech into scar-reduction alliance. Story

> Taris advances human testing of bladder pain treatment delivery device. More

Biomarkers News

> A yogurt a day keeps heart disease biomarkers at bay. Item

> Researchers move closer to ADHD imaging biomarker. News

And Finally... Some cancerous tumors may contain factors that inhibit their own growth. Story

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.